Siamab Therapeutics, Inc.

Siamab develops drugs targeting cancers expressing abnormal carbohydrates (glycans) including ovarian, pancreatic, prostate, and other solid tumors.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Newton, MA, US
  • Currency USD
  • Founded January 2006
  • Employees 4
  • Website siamab.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free